Massimo Lanza
- Physiology top 5%
- Oncology top 10%
- Epidemiology
- Endocrinology, Diabetes and Metabolism top 5%
- Complementary and alternative medicine top 2%
- Co-authors
- Federico SchenaElisabetta BacchiPaolo MoghettiCarlo NegriEnzo BonoraNiccolò FaccioliGiacomo ZoppiniAlice Avancini
- Topics
- Cancer survivorship and care (16 papers)Physical Activity and Health (9 papers)Lymphatic System and Diseases (8 papers)
- Cited by
- Complementary and alternative medicinePhysiologyPhysical Therapy, Sports Therapy and Rehabilitation
- Journals
- PLoS ONEHepatologyDiabetes Care
- Partner nations
- ItalyUnited StatesJapan
In The Last Decade
Massimo Lanza
44 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Physiology 481
- Oncology 273
- Epidemiology 244
- Endocrinology, Diabetes and Metabolism 212
- Complementary and alternative medicine 179
Countries citing papers authored by Massimo Lanza
This map shows the geographic impact of Massimo Lanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Lanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Lanza more than expected).
Fields of papers citing papers by Massimo Lanza
This network shows the impact of papers produced by Massimo Lanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Lanza. The network helps show where Massimo Lanza may publish in the future.
Co-authorship network of co-authors of Massimo Lanza
This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Lanza. A scholar is included among the top collaborators of Massimo Lanza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Lanza. Massimo Lanza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 29 | |
| 9 | 12 | |
| 10 | 63 | |
| 11 | 15 | |
| 12 | 16 | |
| 13 | 14 | |
| 14 | 119 | |
| 15 | 13 | |
| 16 | 265 | |
| 17 | 35 | |
| 18 | 13 | |
| 19 | 15 | |
| 20 | 46 |
About Massimo Lanza
Massimo Lanza is a scholar working on Complementary and alternative medicine, Physiology and Otorhinolaryngology, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer survivorship and care (16 papers), Physical Activity and Health (9 papers) and Lymphatic System and Diseases (8 papers). The work is most often cited by research in Complementary and alternative medicine (179 citations), Physiology (481 citations) and Physical Therapy, Sports Therapy and Rehabilitation (69 citations). Massimo Lanza has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Federico Schena, Elisabetta Bacchi, Paolo Moghetti, Carlo Negri, Enzo Bonora, Niccolò Faccioli, Giacomo Zoppini, Alice Avancini, Michèle Milella and Sara Pilotto. Their work appears in journals such as PLoS ONE, Hepatology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.